Phase III trial of dalbavancin in patients with complicated skin and skin structure infections caused by gram-positive bacteria
Phase of Trial: Phase III
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Dalbavancin (Primary)
- Indications Gram-positive infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- 17 Sep 2008 New trial record.